These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21334742)

  • 1. An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis.
    Moon S; Yang SG; Na K
    Biomaterials; 2011 May; 32(14):3603-10. PubMed ID: 21334742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer.
    Lee JW; Yang SG; Na K
    Int J Pharm; 2012 May; 427(2):276-83. PubMed ID: 22366483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma.
    Xiao JB; Weng JY; Hu YY; Deng GL; Wan XJ
    World J Gastroenterol; 2020 Aug; 26(31):4589-4606. PubMed ID: 32884219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
    Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
    Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model.
    Chung MJ; Kim H; Kim KS; Park S; Chung JB; Park SW
    J Gastroenterol Hepatol; 2012 Feb; 27(2):261-7. PubMed ID: 21793905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
    Tang Z; Feng W; Yang Y; Wang Q
    Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models.
    Matsumoto T; Komori T; Yoshino Y; Ioroi T; Kitahashi T; Kitahara H; Ono K; Higuchi T; Sakabe M; Kori H; Kano M; Hori R; Kato Y; Hagiwara S
    Pharm Res; 2021 Jun; 38(6):1093-1106. PubMed ID: 33961188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
    Nakai Y; Isayama H; Kawabe T; Tsujino T; Yoshida H; Sasaki T; Tada M; Arizumi T; Yagioka H; Kogure H; Togawa O; Ito Y; Matsubara S; Hirano K; Sasahira N; Omata M
    Pancreas; 2008 Nov; 37(4):405-10. PubMed ID: 18953253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photochemical tissue penetration via photosensitizer for effective drug penetration in a non-vascular tumor.
    Min D; Jeong D; Choi MG; Na K
    Biomaterials; 2015 Jun; 52():484-93. PubMed ID: 25818454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation.
    Karavana SY; Şenyiğit ZA; Çalışkan Ç; Sevin G; Özdemir Dİ; Erzurumlu Y; Şen S; Baloğlu E
    Drug Des Devel Ther; 2018; 12():1959-1975. PubMed ID: 29997433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.
    Cosco D; Bulotta A; Ventura M; Celia C; Calimeri T; Perri G; Paolino D; Costa N; Neri P; Tagliaferri P; Tassone P; Fresta M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1009-20. PubMed ID: 19263052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.
    Réjiba S; Reddy LH; Bigand C; Parmentier C; Couvreur P; Hajri A
    Nanomedicine; 2011 Dec; 7(6):841-9. PubMed ID: 21419876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codelivery of dual drugs from polymeric micelles for simultaneous targeting of both cancer cells and cancer stem cells.
    Krishnamurthy S; Ng VW; Gao S; Tan MH; Hedrick JL; Yang YY
    Nanomedicine (Lond); 2015; 10(18):2819-32. PubMed ID: 26377155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
    Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-eluting nanofiber-covered self-expanding nonvascular stent for palliative chemotherapy of gastrointestinal cancer and its related stenosis.
    Kim SY; Kim M; Kim MK; Lee H; Lee DK; Lee DH; Yang SG
    Biomed Microdevices; 2014 Dec; 16(6):897-904. PubMed ID: 25135441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and gemcitabine combinational drug-loaded mucoadhesive delivery system in the treatment of colon cancers.
    Guo XY; Wang P; Du QG; Han S; Zhu SM; Lv YF; Liu GS; Hao ZM
    Drug Res (Stuttg); 2015 Apr; 65(4):199-204. PubMed ID: 24941086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor efficacy of gemcitabine-loaded temperature-sensitive liposome by hyperthermia in tumor-bearing mice.
    Lim SK; Shin DH; Choi MH; Kim JS
    Drug Dev Ind Pharm; 2014 Apr; 40(4):470-6. PubMed ID: 23614830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.
    Wu W; Dai Y; Liu H; Cheng R; Ni Q; Ye T; Cui W
    Drug Deliv; 2018 Nov; 25(1):1642-1651. PubMed ID: 30799654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer.
    Fan K; Fan Z; Cheng H; Huang Q; Yang C; Jin K; Luo G; Yu X; Liu C
    Cancer Med; 2019 Oct; 8(13):5903-5915. PubMed ID: 31426130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model.
    Guo P; Ma J; Li S; Guo Z; Adams AL; Gallo JM
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):169-76. PubMed ID: 11561783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.